Research Article

Thyroid Parameters and Kidney Disorder in Type 2 Diabetes: Results from the METAL Study

Table 1

Clinical characteristics of all participants.

AllMenWomen

413619832153
Age (yr)
Duration of diabetes (yr)9.00 (12.00)10.00 (12.00)8.00 (12.00)
Current smoking (%)18.736.32.4
BMI (kg/m2)
HbA1c (%)7.20 (1.60)7.30 (1.60)7.10 (1.50)
UA (μmol/L)
Hypertension (%)84.684.584.8
Dyslipidemia (%)62.063.560.5
UACR (mg/g Cr)13.00 (23.00)13.00 (24.00)14.00 (23.00)
eGFR (ml/min/1.73 m2)95.63 (18.59)94.56 (18.64)96.66 (18.02)
Reduced eGFR (%)5.586.05.1
Higher UACR (%)26.025.926.2
Higher UACR and/or reduced eGFR (%)28.127.828.4
Thyroid parameters
 TSH (mIU/L)2.53 (1.78)2.33 (1.58)2.73 (1.97)
 FT3 (pmol/L)
 FT4 (pmol/L)
 T3 (nmol/L)
 T4 (nmol/L)
 TPOAb positive (%)7.75.210.0
 TgAb positive (%)6.23.39.0
Thyroid homeostasis parameters
 SPINA-GD (nmol/s)
 SPINA-GT (pmol/s)2.31 (1.05)2.38 (1.05)2.25 (1.06)
 TSHI
 TTSI (m/L)192.32 (132.76)179.96 (122.53)207.08 (143.21)

Normally and nonnormally distributed continuous variables were expressed as and median (interquartile range), respectively. BMI: body mass index; HbA1c: glycated hemoglobin; UA: uric acid; UACR: urinary albumin to creatinine ratio; Cr: creatinine; eGFR: estimated glomerular filtration rate; TSH: thyroid-stimulating hormone; FT3: free triiodothyronine; FT4: free thyroxine; T4: thyroxin; T3: triiodothyronine; TPOAb: thyroid peroxidase antibody: TgAb: thyroglobulin antibody; SPINA-GD: sum activity of peripheral deiodinases; SPINA-GT: thyroid’s secretory capacity; TSHI: Jostel’s TSH index; TTSI: thyrotroph thyroid hormone resistance index.